{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-037558","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.213679+00:00","generated_at":"2026-05-16T05:00:42.428866+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Aligos Therapeutics appoints Nikhil Aneja as Principal Accounting Officer","bullets":["Nikhil Aneja appointed Principal Accounting Officer effective January 29, 2026.","He succeeds Lesley Ann Calhoun, who remains EVP, COO & CFO.","Aneja has served as VP Finance since Feb 2024; prior roles at CareDx, Blade Therapeutics, Global Blood Therapeutics.","Aneja, age 49, is a CPA with a Bachelor of Commerce from University of Delhi."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-037558","json":"https://secwatch.observer/filing/0001193125-26-037558.json","markdown":"https://secwatch.observer/filing/0001193125-26-037558.md","text":"https://secwatch.observer/filing/0001193125-26-037558.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312526037558/0001193125-26-037558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312526037558/d12642d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:00:42.428866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}